Sparano JA - Search Results

1

Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.

Jayasekera J, Li Y, Schechter CB, Jagsi R, Song J, White J, Luta G, Chapman JW, Feuer EJ, Zellars RC, Stout N, Julian TB, Whelan T, Huang X, Shelley Hwang E, Hopkins JO, Sparano JA, Anderson SJ, Fyles AW, Gray R, Sauerbrei W, Mandelblatt J, Berry DA; CISNET-BOLD Collaborative Group. Jayasekera J, et al. Among authors: sparano ja. J Natl Cancer Inst. 2018 Dec 1;110(12):1360-1369. doi: 10.1093/jnci/djy059. J Natl Cancer Inst. 2018. PMID: 29718314 Free PMC article.

2

Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancer.

Wiernik PH, Sklarin NT, Dutcher JP, Sparano JA, Greenwald ES. Wiernik PH, et al. Among authors: sparano ja. Med Oncol. 1994;11(3-4):121-5. doi: 10.1007/BF02999859. Med Oncol. 1994. PMID: 7633831

3

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH. Sparano JA, et al. J Natl Cancer Inst. 1997 Feb 19;89(4):301-7. doi: 10.1093/jnci/89.4.301. J Natl Cancer Inst. 1997. PMID: 9048834

4

Microvessel density and p53 overexpression in young women with breast cancer: a case-control study.

Kalfon B, Fineberg S, Gu Y, Anand K, Dalal A, Jones J, Sparano JA. Kalfon B, et al. Among authors: sparano ja. Clin Breast Cancer. 2001 Apr;2(1):67-72. doi: 10.3816/CBC.2001.n.013. Clin Breast Cancer. 2001. PMID: 11899385

5

Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.

Sparano JA. Sparano JA. Clin Breast Cancer. 2000 Apr;1(1):32-40; discussion 41-2. doi: 10.3816/CBC.2000.n.002. Clin Breast Cancer. 2000. PMID: 11899388 Review.

6

Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical Trials.

Sparano JA, Gray R, Giantonio B, O'Dwyer P, Comis RL; Eastern Cooperative Oncology Group Portfolio of Clinical Trials. Sparano JA, et al. Clin Cancer Res. 2004 Feb 15;10(4):1206-11. doi: 10.1158/1078-0432.ccr-03-0238. Clin Cancer Res. 2004. PMID: 14977816

7

Clinical application of molecular profiling in breast cancer.

Sparano JA, Fazzari MJ, Childs G. Sparano JA, et al. Future Oncol. 2005 Aug;1(4):485-96. doi: 10.2217/14796694.1.4.485. Future Oncol. 2005. PMID: 16556025 Review.

8

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.

Hudis CA, Barlow WE, Costantino JP, Gray RJ, Pritchard KI, Chapman JA, Sparano JA, Hunsberger S, Enos RA, Gelber RD, Zujewski JA. Hudis CA, et al. Among authors: sparano ja. J Clin Oncol. 2007 May 20;25(15):2127-32. doi: 10.1200/JCO.2006.10.3523. J Clin Oncol. 2007. PMID: 17513820

9

Development of the 21-gene assay and its application in clinical practice and clinical trials.

Sparano JA, Paik S. Sparano JA, et al. J Clin Oncol. 2008 Feb 10;26(5):721-8. doi: 10.1200/JCO.2007.15.1068. J Clin Oncol. 2008. PMID: 18258979 Review.

10

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.

Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML, Rowley SC, Shak S, Perez EA, Shulman LJ, Martino S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA. Badve SS, et al. Among authors: sparano ja. J Clin Oncol. 2008 May 20;26(15):2473-81. doi: 10.1200/JCO.2007.13.6424. J Clin Oncol. 2008. PMID: 18487567 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page